Search results
10 hours ago · Mechanobiology studies how cells can sense and respond to mechanical forces. A major challenge in this field is to elucidate the molecular mechanisms that allow cells to sense forces. So far, research has been focused a lot on structures within cells, such as the cytoskeleton and cell adhesions. HITS group leader Frauke Gräter has been ...
10 hours ago · Related: Scientists just discovered a new way cells control their genes — it's called 'backtracking' In their new study of human brain tissue, Ebbert and his colleagues uncovered 700 RNA ...
10 hours ago · Despite the fascinating developments in design and synthesis of artificial molecular machines operating at the nanoscales, translating molecular motion along multiple length scales and inducing mechanical motion of a three-dimensional macroscopic entity remains an important challenge. The key to addressing this amplification of motion relies on the effective organization of molecular machines ...
10 hours ago · More, a lot of scientists, even a lot of biologists, would like to believe that biological phenomena can and will be eventually understood entirely though the means of contemporary physics. In the essay Rosen argues it is in fact the other way around: it is biology that is the more general science and it is contemporary physics that is marginal.
10 hours ago · Marcus Lum. Two scientists were awarded the prestigious Shaw Prize in life science and medicine for their groundbreaking discoveries related to the genetic and molecular mechanisms underlying the ...
10 hours ago · Plants are challenged by different microbial pathogens that affect their growth and productivity. However, to defend pathogen attack, plants use diverse immune responses, such as pattern-triggered immunity (PTI), effector-triggered immunity (ETI), RNA silencing and autophagy, which are intricate and regulated by diverse signaling cascades. Pattern-recognition receptors (PRRs) and nucleotide ...
10 hours ago · Scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
